Position in LUNG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,012
+$14,718 QoQ
Shares Held
11,548
+57640.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 107 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $194,335,431 across 52 Medical Devices names. LUNG ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in LUNG
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,012 | 11,548 | Shares | Sole | 2026-08-13 | |
| 2022-06-30 | $294 | 20 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $5,160 | 208 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $577 | 18 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||